Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study
European Journal of Cancer · 2025-11 · 230 · 116032
DOI: 10.1016/j.ejca.2025.116032 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Cancer, 2025-11. Verfasst von Shaoxiang Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Shanxi Medical University, 030000, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Nursing, Shanxi Medical University, 030000, China.
- School of Nursing, Shanxi Medical University, 030000, China. Electronic address: work7work7@163.com.
Zitieren
APA
Huang, S., Wang, X., & Zhang, P. (2025). Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study. European Journal of Cancer, 230, 116032. https://doi.org/10.1016/j.ejca.2025.116032
Vancouver
Huang S, Wang X, Zhang P. Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study. European Journal of Cancer. 2025;230:116032. doi:10.1016/j.ejca.2025.116032
BibTeX
@article{Huang2025,
author = {Huang, Shaoxiang and Wang, Xueyu and Zhang, Peili},
title = {Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study},
journal = {European Journal of Cancer},
year = {2025},
volume = {230},
pages = {116032},
doi = {10.1016/j.ejca.2025.116032}
}
EUVIMED